Entry into a new class of protein kinase inhibitors by pseudo ring design
- PMID: 18248988
- DOI: 10.1016/j.bmcl.2007.12.041
Entry into a new class of protein kinase inhibitors by pseudo ring design
Abstract
A pyrimidin-4-yl-urea motif forming a pseudo ring by intramolecular hydrogen bonding has been designed to mimic the pyrido[2,3-d]pyrimidin-7-one core structure of a well-established class of protein kinase inhibitors. Potent inhibition of a number of protein kinases was obtained with the first prototype compound synthesized to probe the design concept.
Similar articles
-
Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors.Bioorg Med Chem Lett. 2008 Apr 1;18(7):2355-61. doi: 10.1016/j.bmcl.2008.02.070. Epub 2008 Mar 4. Bioorg Med Chem Lett. 2008. PMID: 18342505
-
Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.Bioorg Med Chem Lett. 2005 Aug 15;15(16):3778-81. doi: 10.1016/j.bmcl.2005.05.100. Bioorg Med Chem Lett. 2005. PMID: 15993060
-
Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors.Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. doi: 10.1016/j.bmcl.2009.10.049. Epub 2009 Oct 26. Bioorg Med Chem Lett. 2009. PMID: 19864136
-
Recent developments in the discovery of protein kinase inhibitors from the urea class.Curr Opin Drug Discov Devel. 2004 Sep;7(5):600-16. Curr Opin Drug Discov Devel. 2004. PMID: 15503863 Review.
-
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.Drug Discov Today. 2007 Aug;12(15-16):622-33. doi: 10.1016/j.drudis.2007.06.008. Epub 2007 Aug 2. Drug Discov Today. 2007. PMID: 17706543 Review.
Cited by
-
Pseudo-Ring Methodology to Control the Conformations of Macrocyclic Peptides.Chemistry. 2025 Apr;31(24):e202500581. doi: 10.1002/chem.202500581. Epub 2025 Mar 27. Chemistry. 2025. PMID: 40051037 Free PMC article.
-
Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry.J Med Chem. 2020 Mar 26;63(6):2751-2788. doi: 10.1021/acs.jmedchem.9b01541. Epub 2019 Dec 2. J Med Chem. 2020. PMID: 31789518 Free PMC article.
-
Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.J Med Chem. 2013 Dec 12;56(23):9693-700. doi: 10.1021/jm4013888. Epub 2013 Nov 20. J Med Chem. 2013. PMID: 24219778 Free PMC article.
-
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.Molecules. 2023 Dec 21;29(1):68. doi: 10.3390/molecules29010068. Molecules. 2023. PMID: 38202651 Free PMC article. Review.
-
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future.Front Chem. 2022 Sep 15;10:995351. doi: 10.3389/fchem.2022.995351. eCollection 2022. Front Chem. 2022. PMID: 36186578 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information